Daniel Velarde
@dvelarde85Cardiologo Centro Medico Nacional del Noroeste IMSS Cardiologo Centro Cardiovascular Clinica Hospital San Jose de Navojoa
Similar User
@drfawazalenezi
@RamonTasmania
@pmidallas
@vgaldana
@jaimeanguloo
@TomasDatino
@chadialraies
@PabloJ
@goldenroy33
@oswaldolagunas
@EnriquezEdwardo
@JuanFDelgado1
@yadersandoval
@KarlaSue8
@DrKareyPerez
"Toda intervención deber hacer que la evolución del paciente sea mejor que la espontánea"
CLEAR results are in Colchicine is out (at least for #AMI) #AHA24 @NEJM AMI tx with colchicine did not ⤵️ incidence of the composite primary outcome (☠️from CV causes, recurrent Mi, stroke, unplanned revascularization) 📎 rb.gy/8pnnhd
Routine Spironolactone in Acute Myocardial Infarction: @NEJM 🥸 Great trials from #AHA24: @AHASc 😱 Summary 👇👇👇
PRIMARY ENDPOINTS MET! We are excited to announce the positive results from OPTION Clinical Trial – the primary endpoints showed WATCHMAN FLX™ was equally effective to OACs, with a superior safety profile at 36 months, which allowed patients to eliminate continuous medication…
SUMMIT trial results presented at #AHA24 show tirzepatide reduced the risk of worsening #heartfailure events & improved #QoL in patients w/ #HFpEF & obesity. “Cardiologists now have an ever-expanding armamentarium to treat HFpEF,” says Dr. @ChrisKramerMD bit.ly/4hSxZ9J
📌 After AF ablation, LAA closure vs OAC ✔️ ⬇️risk of bleeding ✔️ 🟰efficacy to prevent stroke #afib #EPeeps #CardioTwitter #stroke @drjohnm @omwazni @Drdevignair @PrashSanders @DJ_Lakkireddy @DrJasonAndrade @DhirajGuptaBHRS @ShelleyZieroth @tomdepotter @Hragy @ftrae @drluissaenz
Vanish 2 trial: ablación o antiarrítmicos en pacientes con arritmias ventriculares (primera linea) ➡️La ablación mejora los resultados fundamentalmente en términos de reducción de nuevos eventos en el seguimiento. ➡️Los resultados contra sotalol son mejor que contra…
El sedentarismo 🪑 tiene un efecto perjudicial en muestra salud? Por supuesto que sí @JACCJournals Nuevo estudio que lo muestra 👇👇 ▶️ > 10 horas de 🪑 aumentan un 40% el riesgo de insuficiencia cardiaca y un 54% el riesgo de muerte 🫀 🚨 Sedentarismo + ejercicio reduce el…
BPROAD Presented at #AHA24 Intensive SBP lowering in people with Type 2 diabetes and elevated SBP could be beneficial for reducing cardiovascular events, but increased risks of hyperkalemia and symptomatic hypotension suggest the need for careful monitoring.
In patients with heart failure with preserved ejection fraction and obesity, treatment with tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart-failure events than placebo. Full SUMMIT trial results: nej.md/4hRGaTY #AHA24
#Diabetes and #obesity: leveraging heterogeneity for precision medicine This State-of-the-Art Review outlines key advances, study designs, and a roadmap to bridge research with clinical application. academic.oup.com/eurheartj/adva… #CardioMetabolic #EHJ @escardio @ESC_Journals
Original Article: Tirzepatide for Obesity Treatment and Diabetes Prevention (SURMOUNT-1) nej.md/48VdDZp #Endocrinology
Staging Heart Failure with Preserved Ejection Fraction by Assessing Cardiac Chamber Involvement A paradigm shift is required to personalise care and unify our approaches to HFpEF patients for future clinical trials. ecrjournal.com/articles/stagi…
🌍En países de ingresos bajos y medios, el tratamiento de la #diabetes no ha avanzado al ritmo de su aumento 📈, lo que deja una creciente carga en estas regiones. Es vital priorizar programas de detección y tratamiento temprano🩸 #WorldDiabetesDay2024 thelancet.com/journals/lance…
🔴"Atorvastatin and Ezetimibe in Patients with Acute Coronary Syndrome"⤵️ #2024Review #openaccess 🔹ow.ly/4wrJ105OHhb #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular
Over 800 million adults are now living with diabetes worldwide with more than half not receiving treatment, global analysis suggests. On #WorldDiabetesDay, explore the data: hubs.li/Q02Yb3Fg0
A 3-year study of tirzepatide in participants with obesity and prediabetes showed substantial and sustained weight reduction and decreased risk of progression to diabetes with tirzepatide, as compared with placebo. Full SURMOUNT-1 trial results: nej.md/48VdDZp
Adding #enalapril to standard care during #chemotherapy did not prevent #cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy. Get the details: bit.ly/3AJecbJ #JACCCardioOnc #CardioOnc #Anthracycline #BCsm #lymsm #PROACT @akaplatini
🗞️ #CV toxicities of immune therapies for #cancer : #HFA &#Cardio_oncology council @escardio @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd @HFA_President bit.ly/4flVPcr
🆕 Síndrome metabólico en 2024: Causas, diagnóstico y tratamiento. 📕 Nat Rev Dis Primers 📁 Resumen del artículo en cardioteca.com/cardiologia-cl…
Timing of intervention in patients with aortic stenosis. authors.elsevier.com/sd/article/S19…
United States Trends
- 1. Bengals 72,4 B posts
- 2. Chargers 59,7 B posts
- 3. McPherson 10,7 B posts
- 4. Herbert 32 B posts
- 5. Joe Burrow 17,6 B posts
- 6. #BoltUp 4.907 posts
- 7. #CINvsLAC 9.803 posts
- 8. Zac Taylor 3.881 posts
- 9. #BaddiesMidwest 17,6 B posts
- 10. #SNFonNBC N/A
- 11. JK Dobbins 4.013 posts
- 12. Money Mac N/A
- 13. Chiefs 154 B posts
- 14. #WhoDey 1.726 posts
- 15. Harbaugh 14,7 B posts
- 16. Ladd 5.164 posts
- 17. Tee Higgins 3.540 posts
- 18. WWIII 153 B posts
- 19. Russia 745 B posts
- 20. Josh Allen 66,9 B posts
Who to follow
-
الدكتور فواز العنزي
@drfawazalenezi -
juan ramon
@RamonTasmania -
PMI Dallas Chapter
@pmidallas -
Victor G. Aldana
@vgaldana -
Jaime Angulo MD, FSCAI.
@jaimeanguloo -
@TomasDatino
@TomasDatino -
Chadi Alraies, MD FACC FSCAI
@chadialraies -
Pablo Jorge
@PabloJ -
Dr. Solís Vázquez
@goldenroy33 -
Oswaldo Lagunas
@oswaldolagunas -
Eduardo Enriquez
@EnriquezEdwardo -
Juan F Delgado
@JuanFDelgado1 -
Yader Sandoval
@yadersandoval -
Karla Sue MD
@KarlaSue8 -
Karey Pérez
@DrKareyPerez
Something went wrong.
Something went wrong.